Literature DB >> 26405779

A first survey of HPV-based screening in routine cervical cancer screening in Italy.

Guglielmo Ronco1, Paolo Giorgi Rossi, Pamela Giubilato, Annarosa Del Mistro, Marco Zappa, Francesca Carozzi.   

Abstract

Pilot HPV-based cervical screening programmes have recently started in Italy, partly on the strength of a large randomized trial. The Ministry of Health recommended that regions shift toward HPV-based screening in early 2013 and provided guidelines for its application (stand-alone HPV testing by validated methods, cytological triage of HPV positives, beginning at age 30-35, 5-year intervals). A first survey on the 2012 activity was conducted in 2013. In 2012, 19 Italian organized cervical screening programmes from 10 regional programmes invited 311,856 women (8.0%of all women invited for cervical screening in 2012 in Italy) for HPV-based screening; 41.5% complied, with a decreasing North-South trend. Among screened women, 7.9% (range 4.3%-13.9%) were HPV positive, decreasing to 6.6% (range 4.0%-12.4%) when considering women aged 35-64 years. Among HPV positive women, 34.8%(with high variability between programmes: range 11.1%-59.3%) were judged to have ASC-US or more severe cytology (5.3%ASC-US, 26.6%L-SIL, 5.2% H-SIL). Out of all screened women, those referred to colposcopy based on HPV and cytology results were 2.9% (range 0.6%-4.8%), whereas they were 2.0% when considering only women aged 35-64 years.

Entities:  

Mesh:

Year:  2015        PMID: 26405779

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  12 in total

1.  Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.

Authors:  Paolo Giorgi Rossi; Simonetta Bisanzi; Elena Allia; Alessandra Mongia; Francesca Carozzi; Anna Gillio-Tos; Laura De Marco; Guglielmo Ronco; Daniela Gustinucci; Annarosa Del Mistro; Helena Frayle; Anna Iossa; Giulia Fantacci; Giampaolo Pompeo; Elena Cesarini; Simonetta Bulletti; Basilio Passamonti; Martina Rizzi; Maria Gabriella Penon; Alessandra Barca; Maria Benevolo
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

2.  Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.

Authors:  S Gori; J Battagello; D Gustinucci; C Campari; M Zorzi; H Frayle; B Passamonti; G Sartori; S Bulletti; C Fodero; E Cesarini; R Faggiano; A Del Mistro
Journal:  BJOG       Date:  2021-01-12       Impact factor: 6.531

3.  HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.

Authors:  Cinzia Campari; Chiara Fedato; Alessio Petrelli; Manuel Zorzi; Carla Cogo; Adele Caprioglio; Federica Gallo; Livia Giordano; Serena Domenighini; Luigi Pasquale; Sonia Prandi; Marco Zappa; Paolo Giorgi Rossi
Journal:  Infect Agent Cancer       Date:  2015-05-07       Impact factor: 2.965

4.  Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program.

Authors:  Tiziano Maggino; Rocco Sciarrone; Bruno Murer; Maria Rosa Dei Rossi; Chiara Fedato; Michela Maran; Melania Lorio; Marika Soldà; Fiorella Zago; Paolo Giorgi Rossi; Manuel Zorzi
Journal:  Br J Cancer       Date:  2016-08-04       Impact factor: 7.640

5.  Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey.

Authors:  Alessio Petrelli; Paolo Giorgi Rossi; Lisa Francovich; Barbara Giordani; Anteo Di Napoli; Marco Zappa; Concetta Mirisola; Lidia Gargiulo
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

6.  Primary cervical screening with high risk human papillomavirus testing: observational study.

Authors:  Matejka Rebolj; Janet Rimmer; Karin Denton; John Tidy; Christopher Mathews; Kay Ellis; John Smith; Chris Evans; Thomas Giles; Viki Frew; Xenia Tyler; Alexandra Sargent; Janet Parker; Miles Holbrook; Katherine Hunt; Penny Tidbury; Tanya Levine; David Smith; Julietta Patnick; Ruth Stubbs; Sue Moss; Henry Kitchener
Journal:  BMJ       Date:  2019-02-06

7.  Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.

Authors:  Bjørn Westre; Anita Giske; Hilde Guttormsen; Sveinung Wergeland Sørbye; Finn Egil Skjeldestad
Journal:  PLoS One       Date:  2019-11-05       Impact factor: 3.240

8.  LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia.

Authors:  Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Carolina Canto; Nadia La Rosa; Maria Antonietta Cantarella; Giuseppa Spampinato; Aurora Scalisi; Antonella Agodi
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430

9.  Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study.

Authors:  Louise T Thomsen; Susanne K Kjær; Christian Munk; Kirsten Frederiksen; Dorthe Ørnskov; Marianne Waldstrøm
Journal:  Clin Epidemiol       Date:  2020-02-21       Impact factor: 4.790

10.  Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece.

Authors:  Anastasios Skroumpelos; Theodoros Agorastos; Theodoros Constantinidis; Kimon Chatzistamatiou; John Kyriopoulos
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.